Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Erin McClure and Rachel Tomko.
Erin McClure
Connection Strength
6.029
Rachel Tomko
  1. Measuring Within-Individual Cannabis Reduction in Clinical Trials: A Review of the Methodological Challenges. Curr Addict Rep. 2019 Dec; 6(4):429-436.
    View in: PubMed
    Score: 0.735
  2. Introduction to the special issue: Utilizing ambulatory assessment to better understand the etiology, maintenance, treatment, and remission of addictive disorders. Addict Behav. 2018 08; 83:1-4.
    View in: PubMed
    Score: 0.657
  3. Using REDCap for ambulatory assessment: Implementation in a clinical trial for smoking cessation to augment in-person data collection. Am J Drug Alcohol Abuse. 2019; 45(1):26-41.
    View in: PubMed
    Score: 0.653
  4. Determining the impact of cannabis use and severity on tobacco cessation outcomes: study protocol for a prospective tobacco treatment trial. BMC Psychol. 2023 Jan 25; 11(1):25.
    View in: PubMed
    Score: 0.229
  5. A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealth. Drug Alcohol Depend. 2022 03 01; 232:109311.
    View in: PubMed
    Score: 0.214
  6. Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers. Drug Alcohol Depend. 2021 08 01; 225:108815.
    View in: PubMed
    Score: 0.205
  7. Mobile, Remote, and Individual Focused: Comparing Breath Carbon Monoxide Readings and Abstinence Between Smartphone-Enabled and Stand-Alone Monitors. Nicotine Tob Res. 2021 03 19; 23(4):741-747.
    View in: PubMed
    Score: 0.202
  8. Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults. Nicotine Tob Res. 2020 07 16; 22(8):1374-1382.
    View in: PubMed
    Score: 0.192
  9. Examining sex, adverse childhood experiences, and oxytocin on neuroendocrine reactivity in smokers. Psychoneuroendocrinology. 2020 10; 120:104752.
    View in: PubMed
    Score: 0.191
  10. Making pharmacotherapy trials for substance use disorder more efficient: Leveraging real-world data capture to maximize power and expedite the medication development pipeline. Drug Alcohol Depend. 2020 04 01; 209:107897.
    View in: PubMed
    Score: 0.187
  11. Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers. Nicotine Tob Res. 2020 01 27; 22(1):81-88.
    View in: PubMed
    Score: 0.186
  12. The influence of gender and oxytocin on stress reactivity, cigarette craving, and smoking in a randomized, placebo-controlled laboratory relapse paradigm. Psychopharmacology (Berl). 2020 Feb; 237(2):543-555.
    View in: PubMed
    Score: 0.184
  13. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology (Berl). 2020 Feb; 237(2):479-490.
    View in: PubMed
    Score: 0.183
  14. An electronic, smart lighter to measure cigarette smoking: A pilot study to assess feasibility and initial validity. Addict Behav. 2019 11; 98:106052.
    View in: PubMed
    Score: 0.179
  15. Medical Cannabis Use among Adults in the Southeastern United States. Cannabis. 2019 Feb 09; 2(1):53-65.
    View in: PubMed
    Score: 0.174
  16. Methods to reduce the incidence of false negative trial results in substance use treatment research. Curr Opin Psychol. 2019 12; 30:35-41.
    View in: PubMed
    Score: 0.174
  17. Tobacco and cannabis co-use: Drug substitution, quit interest, and cessation preferences. Exp Clin Psychopharmacol. 2019 Jun; 27(3):265-275.
    View in: PubMed
    Score: 0.172
  18. Tobacco and cannabis co-use and interrelatedness among adults. Addict Behav. 2019 03; 90:354-361.
    View in: PubMed
    Score: 0.172
  19. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study. Drug Alcohol Depend. 2018 11 01; 192:59-66.
    View in: PubMed
    Score: 0.169
  20. Acceptability and compliance with a remote monitoring system to track smoking and abstinence among young smokers. Am J Drug Alcohol Abuse. 2018; 44(5):561-570.
    View in: PubMed
    Score: 0.165
  21. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend. 2018 01 01; 182:1-7.
    View in: PubMed
    Score: 0.159
  22. Alcohol consumption as a predictor of reactivity to smoking and stress cues presented in the natural environment of smokers. Psychopharmacology (Berl). 2017 Feb; 234(3):427-435.
    View in: PubMed
    Score: 0.149
  23. Characterization of Salivary Progesterone in Female Smokers. Nicotine Tob Res. 2022 10 26; 24(11):1829-1833.
    View in: PubMed
    Score: 0.056
  24. Gender parity and homophily in the Drug and Alcohol Dependence editorial process. Drug Alcohol Depend. 2022 07 01; 236:109493.
    View in: PubMed
    Score: 0.055
  25. Remote Methods for Conducting Tobacco-Focused Clinical Trials. Nicotine Tob Res. 2020 12 12; 22(12):2134-2140.
    View in: PubMed
    Score: 0.049
  26. Increases in endogenous progesterone attenuate smoking in a cohort of nontreatment seeking women: An exploratory prospective study. Addict Biol. 2021 03; 26(2):e12918.
    View in: PubMed
    Score: 0.048
  27. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial. JAMA Pediatr. 2019 12 01; 173(12):1146-1153.
    View in: PubMed
    Score: 0.046
  28. Pharmacological Treatment of Youth Substance Use Disorders. J Child Adolesc Psychopharmacol. 2019 08; 29(7):559-572.
    View in: PubMed
    Score: 0.044
  29. Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults. Drug Alcohol Depend. 2019 05 01; 198:105-111.
    View in: PubMed
    Score: 0.044
  30. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial. Drug Alcohol Depend. 2018 04 01; 185:17-22.
    View in: PubMed
    Score: 0.041
  31. Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. J Subst Abuse Treat. 2017 10; 81:53-58.
    View in: PubMed
    Score: 0.039
  32. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017 08 01; 177:249-257.
    View in: PubMed
    Score: 0.039
  33. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation. Addict Behav. 2016 12; 63:172-7.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.